Skip to content

Proteinuria in Pre and Post Transplant

Evaluation of Recipients With and Without Proteinuria, Pre and Post Kidney Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01094327
Enrollment
100
Registered
2010-03-26
Start date
2008-02-29
Completion date
2026-11-30
Last updated
2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proteinuria

Keywords

focal segmental glomerulosclerosis

Brief summary

Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transplant specimens pre and post reperfusion to identify where the defects has occured that results in recurrence of proteinuria in a given kidney transplant.

Detailed description

This study will retrospectively review patient's medical records for protein in the urine, blood creatinine and kidney biopsy results. Also character of the fluid used to flush the kidney before transplant will be analyzed.

Interventions

None listed

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 25 Years
Healthy volunteers
No

Inclusion criteria

* Kidney transplant recipients * Pediatric males and females up to the age of 25 years old.

Exclusion criteria

* Transplant recipients other than kidney

Design outcomes

Primary

MeasureTime frameDescription
Explain mechanisms behind the development of proteinuria in patients immediately after receiving a kidney transplantthrough study completion, an average of 5 yearschart review

Countries

United States

Contacts

Primary ContactGeorge Burke, M.D.
gburke@med.miami.edu305-355-5111
Backup ContactLissett Moni
ltueros@med.miami.edu305-243-5235

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026